SCHEMBL20099270

SCHEMBL20099270

CC(C)OCC1C[C@@H](OC(C)C)CN1C(=O)CC(C)C(C)(C)CC(=O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22692688 0.93 — —
SCHEMBL19871862 0.85 — —
SCHEMBL22692680 0.83 — —
SCHEMBL16248511 0.81 DPP4 (0.32) —
SCHEMBL16248519 0.78 DPP4 (0.30) —
SCHEMBL17446584 0.78 DPP4 (0.30) —
SCHEMBL16692598 0.78 DPP4 (0.30) —
SCHEMBL16248518 0.78 DPP4 (0.30) —
SCHEMBL20099250 0.78 — —
SCHEMBL23790886 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220324900-A1 COMPOSITIONS AND METHODS FOR MODULATING ANGIOPOIETIN-LIKE 3 EXPRESSION IONIS PHARMACEUTICALS, INC. (US) 2022-10-13 — — US disclosed
US-11312964-B2 Compositions and methods for modulating growth hormone receptor expression IONIS PHARMACEUTICALS, INC. (US) 2022-04-26 — — US disclosed
US-20210207146-A1 COMPOSITIONS AND METHODS FOR MODULATING GROWTH HORMONE RECEPTOR EXPRESSION IONIS PHARMACEUTICALS, INC. (US) 2021-07-08 — — US disclosed
US-9957504-B2 Compositions and methods for modulating apolipoprotein (a) expression IONIS PHARMACEUTICALS, INC. (US) 2018-05-01 — — US disclosed
Send feedback